Bpifrance backs LimFlow’s $33.5m series C round
Posted on 20 April, 2018 by Chris Torney, reporter
The funding will be used to develop trials in the United States.
French medtech company LimFlow has this week announced the successful close of a series C round of funding worth €27m ($33.5m).
The round was led by Sofinnova Partners and featured returning investors Bpifrance, the French sovereign investment bank, and Singaporean fund Balestier.
See more from this Government Report: France
Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.
Latest magazinePast Issues
Get full online access, the monthly magazine, weekly news alerts, special reports and more.See all subscription options